Sort
16,179 grants matching “malaria”
Manufacturing of Novel Adenovirus Prime-Boost HIV-1 Vaccine
$2,669,207Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2008 · AI
Biodefense and Emerging Infectious Disease and Influenza Vaccine Studies
$2,658,032Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Mechanisms of naturally-acquired immunity to malaria
$2,650,143Peter Crompton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
OPTIMIZATION OF PYRIMIDINYLGUANIDINES AS MALARIA PROPHYLAXIS DRUGS
$2,649,706The Geneva Foundation · · FY2017 · Department of the Army
Optimizing malaria transmission-blocking vaccines with improved platforms
$2,649,684Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Pathogenesis of Acute CNS infection and injury
$2,641,192Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Pathogenesis of CNS infection and injury
$2,641,192Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS
PS10-10121, HQ (PEPFAR): BUILDING GLOBAL CAPACITY FOR DIAGNOSTIC TESTING OF TUBERCULOSIS, MALARIA AND HIV
$2,635,000Heidi Albert · Foundation/Innovative New Diagnostics · U2G · FY2015 · PS
Mechanisms of naturally-acquired immunity to malaria
$2,630,010Peter Crompton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Malaria Vaccine: BSAM
$2,629,000Louis Miller · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
RAPID ACCELERATION OF DIAGNOSTICS (RADX) PROGRAM: TECH PROJECT # 6808: SALIVA-BASED SARS-COV-2 RAPID DIAGNOSTIC TEST
$2,620,000Yoav Neuman · · N02 · FY2021 · HL
Advanced Mass Spectrometry Facility
$2,614,730David Anderson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2012 · DK
SARS-CoV-2: Pathogenesis and Countermeasure Development
$2,585,920Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Epidemiology and Natural History of Cancer-Associated Viruses
$2,581,642Sam M Mbulaiteye · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA
University of Washington Vaccine and Treatment Evaluation Unit
$2,579,381Anna Wald · University Of Washington · UM1 · FY2024 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$2,579,232David S Stephens · Emory University · UM1 · FY2023 · AI
Membrane Remodeling in Viral Infection, Parasite Replication, and Traumatic Brain Injury
$2,579,164Joshua Zimmerberg · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) â Gritstone, Variant, & Pediatric Vaccine Trials
$2,577,219David S Stephens · Emory University · UM1 · FY2021 · AI
Microbial Genome Sequencing: Shotgun Sequencing of Tetrahymena thermophila
$2,567,000Jonathan A Eisen · Institute For Genomic Research · · FY2003 · BIO
Essential gene discovery in the malaria parasite Plasmodium falciparum
$2,566,672Jeffrey D Dvorin · Boston Children'S Hospital · DP2 · FY2013 · AI
Optimizing malaria transmission-blocking vaccines with improved platforms
$2,563,513Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Critical Factors Influencing Echinocandin Resistance in Candida glabrata
$2,558,055David S Perlin · Hackensack University Medical Center · R01 · FY2025 · AI
Assay Work for Malaria Vaccines - VTEU
$2,549,706Emmanuel B Walter · Duke University · N01 · FY2015 · AI
Chemical Biology Design For Malaria
$2,542,500Timothy J Cardozo · New York University School Of Medicine · DP2 · FY2008 · OD
The Genome Analysis Core
$2,530,888Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIC · FY2022 · AI